{"id":19667,"date":"2021-11-17T09:20:19","date_gmt":"2021-11-17T08:20:19","guid":{"rendered":"https:\/\/idibell.cat\/?p=19667"},"modified":"2022-12-20T11:07:00","modified_gmt":"2022-12-20T10:07:00","slug":"lidibell-rep-mes-dun-milio-i-mig-deuros-de-laecc-per-financar-projectes-dinvestigacio-contra-el-cancer","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2021\/11\/lidibell-rep-mes-dun-milio-i-mig-deuros-de-laecc-per-financar-projectes-dinvestigacio-contra-el-cancer\/","title":{"rendered":"L\u2019IDIBELL rep m\u00e9s d\u2019un mili\u00f3 i mig d\u2019euros de l\u2019AECC per finan\u00e7ar projectes d\u2019investigaci\u00f3 contra el c\u00e0ncer"},"content":{"rendered":"
L\u2019Associaci\u00f3 Espanyola Contra el C\u00e0ncer (AECC) destina cada any una gran quantitat d\u2019ajudes econ\u00f2miques per la investigaci\u00f3 del c\u00e0ncer amb l\u2019objectiu final d\u2019acostar els resultats cient\u00edfics als pacients, cosa que es tradu\u00efria en una millora de la detecci\u00f3 preco\u00e7 dels casos, la seva qualitat de vida i un augment de la seva superviv\u00e8ncia.<\/p>\n
A l\u2019IDIBELL, la recerca en c\u00e0ncer \u00e9s una de les 4 \u00e0rees principals, i la que compta amb m\u00e9s grups d\u2019investigaci\u00f3. Els 12 investigadors de l\u2019IDIBELL llistats a continuaci\u00f3 han rebut ajudes de l\u2019AECC per un valor total d\u20191.553.129\u20ac per tal de dur a terme la seva recerca en projectes que abarquen des de l\u2019\u00e0mbit m\u00e9s molecular i de recerca b\u00e0sica fins el contacte directe amb el pacient.<\/p>\n
El Dr. \u00c1lvaro Ayt\u00e9s<\/strong>, cap del grup de recerca en mecanismes de resist\u00e8ncia i progressi\u00f3 en el c\u00e0ncer de pr\u00f2stata<\/strong>, ha rebut una ajuda LAB per treballar per identificar punts d\u00e8bils en les c\u00e8l\u00b7lules tumorals que permetin trobar millors tractaments pel c\u00e0ncer de pr\u00f2stata.<\/p>\n Dins el mateix grup, La Dra. Lidia Franco<\/strong> estudiar\u00e0 amb una ajuda Postdoctoral com potenciar l\u2019activitat de les c\u00e8l\u00b7lules immunit\u00e0ries contra les c\u00e8l\u00b7lules del c\u00e0ncer de pr\u00f2stata, un tumor en el qual les immunoter\u00e0pies no estan donant gaire bon resultat.<\/p>\n Amaia Gonzalez de Zarete<\/strong> es beneficiar\u00e0 d\u2019una ajuda Programa Pr\u00e1cticas Laboratorio Verano que li permetr\u00e0 investigar en el camp de la gen\u00e8tica del c\u00e0ncer.<\/p>\n En el grup de recerca en nutrici\u00f3 i c\u00e0ncer<\/strong>, liderat per el Dr. Antonio Agudo<\/strong>, s\u2019estudiar\u00e0 el paper de la dieta, l\u2019activitat f\u00edsica i la composici\u00f3 corporal en el pron\u00f2stic del c\u00e0ncer de mama gr\u00e0cies a una ajuda Proyectos Estrat\u00e9gicos.<\/p>\n Chaima Zoljami<\/strong> rebr\u00e0 una ajuda Programa Pr\u00e1cticas Laboratorio Curso Acad\u00e9mico per seguir avan\u00e7ant dins el m\u00f3n de la investigaci\u00f3 en processos tumorals.<\/p>\n Dins del Programa Epibell<\/strong>, el Dr. Cristian Ochoa<\/strong> vol avaluar amb l\u2019ajuda Proyectos Estrat\u00e9gicos aconseguida l\u2019\u00fas de les noves tecnologies i d\u2019un sistema de salut digital per millorar el tractament psicol\u00f2gic de pacients amb c\u00e0ncer de pulm\u00f3 avan\u00e7at.<\/p>\n La Dra. Isabel Fabregat<\/strong> i el seu equip s\u2019enfocaran en els c\u00e0ncers de fetge m\u00e9s freq\u00fcents per tal d\u2019avan\u00e7ar en una ter\u00e0pia personalitzada per aquests pacients gr\u00e0cies al finan\u00e7ament de l\u2019ajuda Proyectos Generales.<\/p>\n Jes\u00fas Brenes<\/strong> rebr\u00e0 una ajuda Cl\u00ednico Junior per la identificaci\u00f3 de m\u00e8todes de diagn\u00f2stic no invasius i bioindicadors del c\u00e0ncer orofar\u00edngic causat pel VPH.<\/p>\n Dins del grup d\u2019angiog\u00e8nesi tumoral<\/strong>, liderat pel Dr. Oriol Casanovas<\/strong>, la recerca impulsada per l\u2019ajuda INNOVA es dirigir\u00e0 a desenvolupar un nou tractament per c\u00e0ncers avan\u00e7ats que permeti prevenir la resist\u00e8ncia dels tumors.<\/p>\n El Dr. Pedro Fuentes<\/strong>, investigador postdoctoral en metabolisme i c\u00e0ncer<\/strong> i beneficiari d\u2019una ajuda Postdoctoral, estudiar\u00e0 en c\u00e0ncer colorectal la forma de destruir un escut molecular que fa les c\u00e8l\u00b7lules tumorals resistents a la quimioter\u00e0pia i aix\u00ed tornar-les vulnerables als tractaments.<\/p>\n Dins el grup de recerca en viroter\u00e0pia i immunoter\u00e0pia del c\u00e0ncer<\/strong>, el Dr. Rafael Moreno<\/strong> rebr\u00e0 una ajuda Ideas Semilla per investigar ter\u00e0pies antitumorals basades en la utilitzaci\u00f3 de c\u00e8l\u00b7lules troncals mesenquimals com a vehicles cel\u00b7lulars per a virus que ataquin el c\u00e0ncer.<\/p>\n Finalment, el Dr. Victor Moreno<\/strong>, cap del grup de recerca en c\u00e0ncer colorectal<\/strong>, es centrar\u00e0 en desenvolupar un model per predir el risc de c\u00e0ncer de p\u00e0ncrees i aix\u00ed millorar la detecci\u00f3 preco\u00e7 gr\u00e0cies a l\u2019ajuda ERA PerMed.<\/p>\n <\/p>\n <\/p>\n L\u2019Institut d\u2019Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l\u2019Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l\u2019Institut Catal\u00e0 de la Salut, l\u2019Institut Catal\u00e0 d\u2019Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n L\u2019IDIBELL \u00e9s membre del Campus d\u2019Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L\u2019any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" L\u2019Associaci\u00f3 Espanyola Contra el C\u00e0ncer (AECC) destina cada any una gran quantitat d\u2019ajudes econ\u00f2miques per la investigaci\u00f3 del c\u00e0ncer amb l\u2019objectiu final d\u2019acostar els resultats cient\u00edfics als pacients, cosa que es tradu\u00efria en una millora de la detecci\u00f3 preco\u00e7 dels casos, la seva qualitat de vida i un augment de la seva superviv\u00e8ncia. A l\u2019IDIBELL, […]<\/p>\n","protected":false},"author":8,"featured_media":19669,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[397,332,375,453,395,408,369,454,447,517,360],"tags":[],"class_list":["post-19667","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-angiogenesi-tumoral","category-cancer","category-colorectal","category-viroterapia-del-cancer","category-mecanismes-de-resistencia-i-progressio-en-el-cancer-de-prostata","category-metabolisme-del-cancer","category-nutricio-i-cancer","category-p-depidemiologia-salut-publica-prevencio-del-cancer-i-cures-palliatives","category-p-de-mecanismes-molelculars-i-terapia-experimental-en-oncologia-oncobell","category-psicooncologia-i-salut-digital-psodig","category-tgf-beta-i-cancer"],"publishpress_future_action":{"enabled":false,"date":"2025-01-25 09:14:12","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/19667","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=19667"}],"version-history":[{"count":4,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/19667\/revisions"}],"predecessor-version":[{"id":19672,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/19667\/revisions\/19672"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/19669"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=19667"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=19667"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=19667"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}